LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,185 | -41,912 | -21,313 | -17,935 | -7,737 |
| Depreciation Amortization | 730 | 347 | 17 | 5 | N/A |
| Accounts payable and accrued liabilities | 3,600 | 2,322 | -104 | 742 | N/A |
| Other Working Capital | 4,125 | 3,294 | -663 | 823 | -4 |
| Other Operating Activity | 11,021 | 10,766 | 9,184 | 11,631 | 5,606 |
| Operating Cash Flow | $-58,709 | $-25,183 | $-12,879 | $-4,734 | $-2,135 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,218 | -1,816 | -258 | -43 | N/A |
| Investing Cash Flow | $-2,218 | $-1,816 | $-258 | $-43 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 149 | 104,911 | 53,063 | 6,751 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 3,250 | 500 |
| Financing Cash Flow | $149 | $104,911 | $53,063 | $10,001 | $500 |
| Beginning Cash Position | 126,704 | 48,555 | 8,629 | 3,405 | 5,040 |
| End Cash Position | 65,926 | 126,467 | 48,555 | 8,629 | 3,405 |
| Net Cash Flow | $-60,778 | $77,912 | $39,926 | $5,224 | $-1,635 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,709 | -25,183 | -12,879 | -4,734 | -2,135 |
| Capital Expenditure | -2,218 | -1,816 | -258 | -43 | 0 |
| Free Cash Flow | -60,927 | -26,999 | -13,137 | -4,777 | -2,135 |